Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Ray Kennedy Cup 2016 lead

Health & Fitness

Game on: your invite to Parkinson’s football ‘World Cup’

Forget Euro 2016 and the Copa, there’s another tournament in town

READ MORE

Resources & Tools

Brush up on your Parkinson’s terminology with this free glossary

Free downloadable and printable A-Z of Parkinson’s disease

READ MORE
Parkinson's

Europe

“The beginning of a wonderful collaboration between countries, organisations and people”

The EPDA hosted a two-day event last week

READ MORE